Lunai Bioworks Inc. cotiza a 1.11 USD y tiene una capitalización bursátil de $5M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccine…
| Periodo | 2026-10 |
|---|---|
| Real | — |
| Estimado | — |
| Sorpresa | — |
| Métrica | LNAI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -2162.7% | -32.0% | -2130.7% |
| Current Ratio | 0.04 | 2.84 | -2.80 |
| Debt / Equity | — | 0.28 | — |